Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Fisher

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Rheumatology|December 19, 2024
The effect of smoking on Sjögren's disease development and severity: a comprehensive literature reviewMatilde Bandeira, Benjamin A Fisher
Rheumatology (Oxford, England)|February 7, 2020
Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'?Florian Kollert, Benjamin A Fisher
Arthritis Research & Therapy|December 8, 2015
Stratifying primary Sjögren's syndrome: killers in the balance?Simon J Bowman, Benjamin A Fisher
Rheumatology (Oxford, England)|December 10, 2019
Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspectiveNeil M Steven, Benjamin A Fisher
Rheumatology (Oxford, England)|February 17, 2019
Health-related quality of life and costs in Sjögren's syndromeSamira T Miyamoto, Valéria Valim, Benjamin A Fisher
The Lancet. Rheumatology|January 26, 2024
Rationale for CD40 pathway blockade in autoimmune rheumatic disordersValentina Pucino, David H Gardner, Benjamin A Fisher
Expert Review of Clinical Immunology|November 13, 2013
The case for measuring antibodies to specific citrullinated antigensAnna B Montgomery, Patrick J Venables, Benjamin A Fisher
Swiss Medical Weekly|September 17, 2015
The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's SyndromeFrancesca Barone, Joana Campos, Simon Bowman, et al.
Annals of the Rheumatic Diseases|June 3, 2015
A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarkerBenjamin A Fisher, Rachel M Brown, Simon J Bowman, et al.
RMD Open|June 24, 2026
Emerging treatments for Sjögren's disease: promising drugs on the horizonCarlos Marques-Gomes, Simon J Bowman, Saba Nayar, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Rheumatology|December 19, 2024
The effect of smoking on Sjögren's disease development and severity: a comprehensive literature reviewMatilde Bandeira, Benjamin A Fisher
Rheumatology (Oxford, England)|February 7, 2020
Equal rights in autoimmunity: is Sjögren's syndrome ever 'secondary'?Florian Kollert, Benjamin A Fisher
Arthritis Research & Therapy|December 8, 2015
Stratifying primary Sjögren's syndrome: killers in the balance?Simon J Bowman, Benjamin A Fisher
Rheumatology (Oxford, England)|December 10, 2019
Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspectiveNeil M Steven, Benjamin A Fisher
Rheumatology (Oxford, England)|February 17, 2019
Health-related quality of life and costs in Sjögren's syndromeSamira T Miyamoto, Valéria Valim, Benjamin A Fisher
The Lancet. Rheumatology|January 26, 2024
Rationale for CD40 pathway blockade in autoimmune rheumatic disordersValentina Pucino, David H Gardner, Benjamin A Fisher
Expert Review of Clinical Immunology|November 13, 2013
The case for measuring antibodies to specific citrullinated antigensAnna B Montgomery, Patrick J Venables, Benjamin A Fisher
Swiss Medical Weekly|September 17, 2015
The value of histopathological examination of salivary gland biopsies in diagnosis, prognosis and treatment of Sjögren's SyndromeFrancesca Barone, Joana Campos, Simon Bowman, et al.
Annals of the Rheumatic Diseases|June 3, 2015
A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarkerBenjamin A Fisher, Rachel M Brown, Simon J Bowman, et al.
RMD Open|June 24, 2026
Emerging treatments for Sjögren's disease: promising drugs on the horizonCarlos Marques-Gomes, Simon J Bowman, Saba Nayar, et al.
Pageof 9